Induction of a Th2 immune response by co-administration of recombinant adenovirus vectors encoding amyloid β-protein and GM-CSF

Vaccine

Volumn 23, Issue 23, 2005, Pages 2977-2986

  Kim, Hong Duck ^a   Cao, Yunpeng ^a,d   Kong, Fan Kun ^c   Van Kampen, Kent R ^c   Lewis, Terry L ^a   Ma, Zhendong ^a   Tang, De Chu C ^b,c   Fukuchi, Ken Ichiro ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c Vaxin Incorporated   (United States)

^d CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer disease; Granulocyte macrophage colony stimulating factor; Vaccine

Indexed keywords

ADENOVIRUS VECTOR; AMYLOID BETA PROTEIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH2 CELL; VACCINATION; VIRUS RECOMBINANT;

EID: 16244379191     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.12.015     Document Type: Article

References (37)

1. M.P. Lambert, K.L. Viola, and B.A. Chromy Vaccination with soluble Abeta oligomers generates toxicity-neutralizing antibodies J Neurochem 79 2001 595 605
2. D.M. Walsh, I. Klyubin, and J.V. Fadeeva Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539
3. D. Schenk, R. Barbour, and W. Dunn Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 1999 173 177
4. D. Morgan, D.M. Diamond, and P.E. Gottschall A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease Nature 408 2000 982 985
5. C. Janus, J. Pearson, and J. McLaurin A beta peptide immunization reduces behavioral impairment and plaques in a model of Alzheimer's disease Nature 408 2000 979 982
6. E. Check Nerve inflammation halts trial for Alzheimer's drug Nature 415 2002 462
7. J.M. Orgogonzo, S. Gilman, and J.F. Dartigues Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization Neurology 61 2003 46 54
8. W.M. McDonnell, and F.K. Askari DNA vaccines N Engl J Med 334 1996 42 45
9. Z. Shi, M. Zeng, and G. Yang Protection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccines J Virol 75 23 2001 11474 11482
10. G. Dranoff GM-CSF-secreting melanoma vaccines Oncogene 22 20 2003 3188 3192
11. M. Martinez-Moczygemba, and D.P. Huston Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF J Allergy Clin Immunol 112 4 2003 653 665
12. M. Kozak Determinants of translational fidelity and efficiency in vertebrate mRNAs Biochimie 76 1994 815 821
13. M. Okabe, M. Ikawa, K. Kominami, T. Nakanishi, and Y. Nishimune 'Green mice' as a source of ubiquitous green cells FEBS Lett 407 1997 313 319
14. H. Niwa, K. Yamamura, and J. Miyazaki Efficient selection for high-expression transfectants with a novel eukaryotic vector Gene 108 1991 193 200
15. K. Fukuchi, D.D. Kunkel, and P.A. Schwartzkroin Overexpression of a C-terminal portion of the β-amyloid precursor protein in mouse brains by transplantation of transformed neuronal cells Exp Neurol 127 1994 253 264
16. K. Fukuchi, K. Kamino, S.S. Deeb, A.C. Smith, T. Dang, and G.M. Martin Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicity Biochem Biophys Res Commun 182 1992 165 173
17. K. Fukuchi, M.G. Hearn, and S.S. Deeb Activity assays of nine heterogeneous promoters in neural and other cultured cells In Vitro Cell Dev Biol Anim 30A 1994 300 305
18. K. Fukuchi, D. Pham, M. Hart, L. Li, and J.R. Lindsey Amyloid-beta deposition in skeletal muscle of transgenic mice: possible model of inclusion body myopathy Am J Pathol 153 1998 1687 1693
19. C.T. Lee, S. Wu, and I.F. Ciernik Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor Hum Gene Ther 8 1997 187 193
20. K. Fukuchi, L. Ho, and S.G. Younkin High levels of β-amyloid protein in peripheral blood do not cause cerebral ß-amyloidosis in transgenic mice Am J Pathol 149 1996 219 227
21. E.T. Spooner, R.V. Desai, C. Mori, J.F. Leverone, and C.A. Lemere The generation and characterization of potentially therapeutic Aβ antibodies in mice: differences according to strain and immunization protocol Vaccine 21 2002 290 297
22. Y. Nakamura, K.N. Wada, H. Doi, S. Kanaya, T. Gojobori, and T. Ikemura Codon usage tabulated from the international DNA sequence databases Nucleic Acids Res. 24 1996 214 215
23. L.W. Kwak, H.A. Young, R.W. Pennington, and S.D. Weeks Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response Proc Natl Acad Sci USA 93 20 1996 10972 10977
24. Y. Kinoshita, T. Kono, and R. Yasumoto Antitumor effect on murine renal cell carcinoma by autologous tumor vaccines genetically modified with granulocyte-macrophage colony-stimulating factor and interleukin-6 cells J Immunother 24 3 2001 205 211
25. W.M. Aarts, J. Schlom, and J.W. Hodge Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity Cancer Res 62 20 2002 5770 5777
26. M.L. Disis, F.M. Shiota, D.G. McNeel, and K.L. Knutson Soluble cytokines can act as effective adjuvants in plasmid DNA vaccines targeting self tumor antigens Immunobiology 207 3 2003 179 186
27. J. Nemunaitis, D. Sterman, and D. Jablons Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer J Natl Cancer Inst 96 4 2004 326 331
28. J. Wang, D.P. Snider, and B.R. Hewlett Transgenic expression of granulocyte-macrophage colony-stimulating factor induces the differentiation and activation of a novel dendritic cell population in the lung Blood 95 2000 2337 2345
29. P.J. Morrissey, L. Bressler, L.S. Park, A. Alpert, and S. Gillis Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells J Immunol 139 1987 1113 1119
30. A. Tazi, F. Bouchonnet, M. Grandsaigne, L. Boumsell, A.J. Hance, and P. Soler Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers J Clin Invest 91 1993 566 576
31. R. Stampfli, R.E. Wiley, and G.S. Neigh GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice J Clin Invest 102 1998 1704 1714
32. J.F. Leverone, E.T. Spooner, H.K. Lehman, J.D. Clements, and C.A. Lemere Abeta1-15 is less immunogenic than Abeta1-40/42 for intranasal immunization of wild-type mice but may be effective for "boosting" Vaccine 21 17-18 2003 2197 2206
33. J. McLaurin, R. Cecal, and M.E. Kierstead Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis Nat Med 8 11 2002 1263 1269
34. E.T. Spooner, R.V. Desai, C. Mori, J.F. Leverone, and C.A. Lemere The generation and characterization of potentially therapeutic Abeta antibodies in mice: differences according to strain and immunization protocol Vaccine 21 3-4 2002 290 297
35. T. Town, J. Tan, N. Sansone, D. Obregon, T. Klein, and M. Mullan Characterization of murine immunoglobulin G antibodies against human amyloid-beta1-42 Neurosci Lett 307 2 2001 101 104
36. C.A. Lemere, E.T. Spooner, J.F. Leverone, C. Mori, and J.D. Clements Intranasal immunotherapy for the treatment of Alzheimer's disease: Escherichia coli LT and LT(R192G) as mucosal adjuvants Neurobiol Aging 23 6 2002 991 1000
37. A. Monsonego, R. Maron, V. Zota, D.J. Selkoe, and H.L. Weiner Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease Proc Natl Acad Sci USA 98 18 2001 10273 10278